Denali Therapeutics Inc. (DNLI) › Weighted Average Diluted SharesDenali Therapeutics Inc. (DNLI) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2018-12-31: 92.62M2019-12-31: 95.61M2020-12-31: 112.70M2021-12-31: 121.52M2022-12-31: 125.53M2023-12-31: 137.37M2024-12-31: 164.47M2025-12-31: 172.65M172.65M2018-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31172.65M+5.0%2026-02-26From 2025-01-012024-12-31164.47M+19.7%2026-02-26From 2024-01-012023-12-31137.37M+9.4%2026-02-26From 2023-01-012022-12-31125.53M+3.3%2025-02-27From 2022-01-012021-12-31121.52M+7.8%2024-02-28From 2021-01-012020-12-31112.70M+17.9%2023-02-27From 2020-01-012019-12-3195.61M+3.2%2022-02-28From 2019-01-012018-12-3192.62M—2021-02-26From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)